HIMS & Hers Health (NYSE: HIMS) is scheduled to release its first quarter 2025 financial results Monday after the market closes. The telemedicine company will host a conference call at 5 p.m. CDT to discuss the outcome.
Analysts surveyed by Capital IQ anticipate the company will report revenue of $260.91 million for the quarter. The consensus forecast also projects earnings per share at $0.03.
The upcoming HIMS earnings report follows a year the company described as validating its business model and product adoption. Hims & Hers has broadened its offerings beyond its initial focus on men's health to include treatments for mental health, dermatology, and weight loss.
Co-Founder and CEO Andrew Dudum previously characterized 2024 as a year confirming the effectiveness of the company's integrated approach. This model incorporates in-house pharmacy operations, clinical services, and marketing.
The company ended last year with 2.2 million subscribers, representing a 45% increase compared to the previous year. CFO Yemi Okupe noted that growing leverage stemmed from disciplined spending on customer acquisition and an increase in the average amount customers spend as they use services across multiple health categories.
Key areas of investor focus for the first quarter results include the performance of the company's GLP-1 program, launched in 2024. Dudum indicated this program is expected to be a meaningful contributor to revenue growth during 2025. Observers will look for early indicators regarding the scale of prescription fulfillment and customer uptake in this area.
Other newer initiatives in dermatology and cardiovascular health are also on analysts' radar. These areas remain in early stages but are considered central to the company's long-term strategy.
Historically, the stock has shown volatility around earnings announcements. Over the past five years, HIMS stock has recorded a negative one-day return following earnings in 56% of instances. The median negative return in these cases was -5.8%, with a maximum decrease of -22.3% recorded in one instance. Positive one-day returns were observed in approximately 44% of earnings announcements over the same period. (See earnings reaction history of all stocks)
Trailing twelve-month financial data shows the company has a market capitalization of $7.7 billion. Revenue over that period reached $1.5 billion, resulting in $62 million in operating profits and a net income of $126 million. (How Will Hims Stock React To Its Upcoming Earnings?)